Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros

Base de dados
País como assunto
Tipo de documento
Intervalo de ano de publicação
1.
Lasers Surg Med ; 56(4): 321-333, 2024 04.
Artigo em Inglês | MEDLINE | ID: mdl-38506454

RESUMO

BACKGROUND: Port wine birthmark (PWB) is a congenital vascular malformation of the skin. Pulsed dye laser (PDL) is the "gold standard" for the treatment of PWB globally. Hematoporphyrin monomethyl ether (HMME or hemoporfin)-mediated photodynamic therapy (HMME-PDT) has emerged as the first choice for PWB treatment, particularly for young children, in many major hospitals in China during the past several decades. AIM: To evaluate whether HMME-PDT is superior to PDL by comparing the clinical efficacies of both modalities. METHOD: PubMed records were searched for all relevant studies of PWB treatment using PDL (1988-2023) or HMME-PDT (2007-2023). Patient characteristics and clinical efficacies were extracted. Studies with a quartile percentage clearance or similar scale were included. A mean color clearance index (CI) per study was calculated and compared among groups. An overall CI (C0), with data weighted by cohort size, was used to evaluate the final efficacy for each modality. RESULT: A total of 18 HMME-PDT studies with 3910 patients in China were eligible for inclusion in this analysis. Similarly, 40 PDL studies with 5094 patients from nine different countries were eligible for inclusion in this analysis. Over 58% of patients in the HMME-PDT studies were minors (<18 years old). A significant portion (21.3%) were young children (<3 years old). Similarly, 33.2% of patients in the PDL studies were minors. A small proportion (9.3%) was young children. The overall clearance rates for PDL were slightly, but not significantly, higher than those for HMME-PDT in cohorts with patients of all ages (C0, 0.54 vs. 0.48, p = 0.733), subpopulations with only minors (C0, 0.54 vs. 0.46, p = 0.714), and young children (C0, 0.67 vs. 0.50, p = 0.081). Regrettably, there was a lack of long-term data on follow-up evaluations for efficacy and impact of HMME-PDT on young children in general, and central nervous system development in particular, because their blood-brain barriers have a greater permeability as compared to adults. CONCLUSION: PDL shows overall albeit insignificantly higher clearance rates than HMME-PDT in patients of all ages; particularly statistical significance is nearly achieved in young children. Collectively, current evidence is insufficient to support HMME-PDT as the first choice of treatment of PWBs in young children given: (1) overall inferior efficacy as compared to PDL; (2) risk of off-target exposure to meningeal vasculature during the procedure; (3) administration of steriods for mitigation of side effects; -and (4) lack of long-term data on the potential impact of HMME on central nervous system development in young children.


Assuntos
Lasers de Corante , Fotoquimioterapia , Mancha Vinho do Porto , Criança , Adulto , Humanos , Pré-Escolar , Adolescente , Fotoquimioterapia/métodos , Hematoporfirinas/uso terapêutico , Resultado do Tratamento , Mancha Vinho do Porto/tratamento farmacológico , Lasers de Corante/uso terapêutico , China , Fármacos Fotossensibilizantes/uso terapêutico
2.
Lasers Surg Med ; 56(8): 689-690, 2024 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-39171659

Assuntos
Humanos
3.
Australas J Dermatol ; 59(4): e258-e261, 2018 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-29498756

RESUMO

Atopic dermatitis is a multifactorial skin disease characterised by chronic and relapsing inflammation whose pathogenesis is incompletely understood. We found that the expression of TGFßR1 and the activation of SMAD2, RhoA, JNK, PKC-ßII/δ and c-Src were upregulated in the infiltrated inflammatory cells, fibroblasts and vasculatures in the dermis and epidermis. In addition, increases in the expression of TGFßR1 and phosphorylation levels of JNK and c-Src were positively correlated with the inflammatory progression of atopic dermatitis severity.


Assuntos
Dermatite Atópica/metabolismo , Derme/metabolismo , Epiderme/metabolismo , Adolescente , Adulto , Idoso , Feminino , Humanos , Proteínas Quinases JNK Ativadas por Mitógeno/metabolismo , Masculino , Pessoa de Meia-Idade , Fosforilação , Proteína Quinase C beta/metabolismo , Receptor do Fator de Crescimento Transformador beta Tipo I/metabolismo , Índice de Gravidade de Doença , Proteína Smad2/metabolismo , Regulação para Cima , Adulto Jovem , Proteína rhoA de Ligação ao GTP/metabolismo , Quinases da Família src/metabolismo
4.
Lasers Surg Med ; 49(2): 137-159, 2017 02.
Artigo em Inglês | MEDLINE | ID: mdl-28220946

RESUMO

Gynecologist and plastic surgeons pioneered the application of lasers in medicine and surgery almost 5 decades ago, initially used to treat cervical and vaginal pathologies. Ever since, energy-based devices have been deployed to treat pelvic pathologies and improve fertility. Recent technological developments triggered an unprecedented wave of publications, assessing the efficacy of fractional laser, and radiofrequency on the vaginal wall in reversing natural aging processes. Studies have shown that a certain degree of thermal energy deposited on the vaginal wall stimulates proliferation of the glycogen-enriched epithelium, neovascularization, and collagen formation in the lamina propria, and improves natural lubrication and control of urination. This review aimed to review such data and to guide future research. A unique assembly of experts from around the globe, compiled and edited this manuscript based on a thorough literature review and personal experience. Lasers Surg. Med. 49:137-159, 2017. © 2017 Wiley Periodicals, Inc.


Assuntos
Doenças Urogenitais Femininas/terapia , Terapia a Laser , Menopausa , Feminino , Doenças Urogenitais Femininas/etiologia , Doenças Urogenitais Femininas/patologia , Humanos , Síndrome
5.
Facial Plast Surg ; 28(5): 518-24, 2012 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-23027219

RESUMO

Recent advances in optical technologies have produced laser systems capable of optimizing the appearance of scars from various etiologies. Laser treatment can commence as early as the time of the initial injury and as late as several years after the injury. Optimal results can now be attained with minimal down time. Herein, we review several available optical technologies for treatment of surgical, traumatic, and inflammatory scars, based upon our clinical experience.


Assuntos
Cicatriz/terapia , Terapia a Laser/métodos , Cicatrização/efeitos da radiação , Cicatriz/classificação , Procedimentos Cirúrgicos Dermatológicos/métodos , Humanos , Lasers/classificação , Procedimentos de Cirurgia Plástica/instrumentação , Procedimentos de Cirurgia Plástica/métodos
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa